Who invested in Aprecia Pharmaceuticals

9 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$123Mraised across 9 rounds since 2007, from 9 sources

$139KVenture$500KVenture$5.5MVenture$3.9MVenture$26MVenture$4.0MDebt$15MDebt$39MDebt$30MRound

Latest round: Round, $30MJul 2016
Biggest round: $39MDebt · Aug 2015
Investors: 3

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20072009201120132015

$139KVenture$500KVenture$5.5MVenture$3.9MVenture$26MVenture$4.0MDebt$15MDebt$39MDebt$30MRound

First round: Venture, $139K
Biggest round: $39M
Usual gap between rounds: 12 months

The rounds

Jul 2016
Round$30M1 new
- Hercules Capital
Reported by Prnewswire
Aug 2015
Debt$39M
No investor was named in the report.
From a historical funding recordSEC filing: $39M sold, first sale Aug 2015
Dec 2013
Debt$15M
No investor was named in the report.
Reported by sec.govSEC filing: $15M sold, first sale Nov 2013
Nov 2012
Debt$4.0M
No investor was named in the report.
Reported by sec.govSEC filing: $4.0M sold, first sale Nov 2012
Nov 2011
Venture$26M
No investor was named in the report.
Reported by philly.citybizlist.comSEC filing: $26M sold, first sale Oct 2011
Dec 2010
Venture$3.9M
No investor was named in the report.
From a historical funding recordSEC filing: $3.9M sold, first sale Oct 2010
Jan 2010
Venture$5.5M
No investor was named in the report.
Reported by sec.govSEC filing: $5.5M sold, first sale Dec 2009
May 2009
Venture$500K
No investor was named in the report.
From a historical funding recordSEC filing: $500K sold, first sale May 2009
May 2007
Venture$139K2 new
- Alpha Capital
- Harborview Capital Group
From a historical funding record